CPHA Canvax

"This document provides a summary of the National Advisory Committee on Immunization (NACI) Statement of November 19, 2021: Recommendation on the use of the PfizerBioNTech COVID-19 vaccine (10 mcg) in children 5-11 years of age" - Public Health Agency of Canada


Related Resources


Implementation Tool



Vaccine Safety and Development,Vaccine Safety,Vaccine Safety,Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Vaccine Management,Allocation and Distribution,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and Development
Vaccine Safety
Vaccine Safety
Program Planning and Delivery
Program Delivery and Evaluation
Vaccine Management
Allocation and Distribution
Monitoring and Surveillance
Outbreaks and Pandemics


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.